[68 Ga] Ga-PentixaFor, a PET agent targeting CXCR4 is emerging as a versatile radiotracer
with promising applications in oncology, cardiology and inflammatory disease. Preclinical …

Inflammation is an important component of several chronic and debilitating diseases that
result in significant morbidity and mortality. This is best evidenced within the cardiovascular …

CXC-motif chemokine receptor 4 (CXCR4) is a novel predictive biomarker for metastasis
and poor prognosis in individuals with malignancies. CXCL12 is the only cognate ligand of …

Until now, very few efforts have been made to specifically trace, monitor, and visualize
implantations, artificial organs, and bioengineered scaffolds for tissue engineering in vivo …

Theranostics with radioligands (radiotheranostics) has played a pivotal role in oncology.
Radiotheranostics explores the molecular targets expressed on tumor cells to target them for …

Over the past two decades, more than 50,000 papers with keyword PET/computed
tomography (CT) have been published. Most of these pertain to the role of PET/CT in …

Objectives This study aimed to determine the correlation of [68Ga] Ga-NODAGAZOL uptake
in atherosclerotic plaques and the cardiovascular risk profile of patients imaged with …

Objective We aimed to perform a qualitative synthesis of evidence on the role of 68Ga-
Pentixafor PET in atherosclerosis. Methods A systematic search of the PubMed and Embase …

Cardiac sarcoidosis (CS) is an inflammatory disease with high morbidity and mortality, with a
pathognomonic feature of non-caseating granulomatous inflammation. While 18 F …

Der Chemokinrezeptor CXCR4–häufig nachgewiesen, doch selten greifbar. Während in
einer schier endlosen Zahl an Studien seine physiologische und pathogene Präsenz, seine …